According to the Hong Kong text Exchange Network, the martial arts novel, Jin Yong, suffered from liver cancer in his later years and died in Hong Kong in the afternoon of October 30 at the age of 94. From 1955 using the pseudonym ' Jin Yong ' serial martial arts novel Virgo "book Sword enmity Record", to 1972 to complete the "Deer Ding Ji" After the pen, Jin Yong wrote a total of 15 famous martial arts novels, it is no exaggeration to say that Mr. Jin Yong's works accompanied the growth of generations, even if not read his book,
But he has also seen a film and television drama adapted from his work. Mr. Jin Yong died when died and shocked too many people.
Hepatocellular carcinoma is the second highest mortality rate in China, and high-risk groups should actively prevent the occurrence of hepatocellular carcinoma.
Are you a high risk group for liver cancer?
There is a long history of alcoholism, chronic hepatitis B, hepatitis C patients and hepatitis virus carriers and clinically diagnosed as cirrhosis of the population is susceptible to liver cancer.
Hepatocellular Carcinoma Screening Trilogy
Elevated nail fetoprotein or ' warning ' for primary hepatocellular carcinoma
High-risk groups, especially patients with positive hepatitis B surface antigen, screening for liver cancer interval should not exceed one year, the best half-year to do ' a fetus + hepatitis B three half + B Super ' combination examination.
The content of serum nail Fetoprotein in normal people is very low, and when the content of nail fetoprotein detection is obviously increased, it is necessary to be wary of primary hepatocellular carcinoma.
Secondly, hepatitis B three-half detection can check the body has no infection with HBV and the amount of virus replication. If the hepatitis B surface antigen is negative, indicating that the possibility of HBV infection is very small, the possibility of liver cancer can be ruled out more than half.
Finally, B-Ultrasound, CT examination can check the liver has no lumps and other abnormalities.
Standard for detection of nail fetoprotein
The results of a positive or quantitative determination of alpha Fetoprotein exceeding 400 ng/ml and lasting 1 months, or a fetal protein exceeding 200 ng/ml and lasting 2 months, and can exclude pregnancy, active liver disease, gonadal embryonic tumor, etc., can be considered as liver cancer.
Hepatitis B patients ' no symptoms ' should also be wary At present, the detection rate of early hepatocellular carcinoma is relatively low, many people feel that ' no symptoms on behalf of no disease '.
However, the early symptoms of hepatocellular carcinoma are not obvious, patients almost do not feel different, when the body appears unwell, such as abdominal pain, eat no food, swelling ascites and other significant symptoms only to visit the hospital, often to the late stage of hepatocellular carcinoma. Therefore, hepatitis patients, especially hepatitis B surface antigen positive patients can not be careless.
Secondary prevention requires ' three early ', that is, early detection, early diagnosis, early treatment, high-risk groups to take the initiative, and actively carry out relevant screening.
When the following symptoms occur in high-risk groups, be wary of whether they are liver cancer:
Rational application of various treatment methods Once liver cancer is diagnosed, it must be treated early. There are many means to treat hepatocellular carcinoma. Among them, Hepatectomy is still the most effective radical method at present.
Liver transplantation is mainly suitable for patients with small hepatocellular carcinoma complicated with severe cirrhosis.
There are many treatments for hepatocellular carcinoma, in addition to a variety of local treatment, there are a variety of systemic treatment methods, including chemotherapy, biological therapy, endocrine therapy, Traditional Chinese medicine treatment and molecular targeted therapy.
Only by rational application of various treatment methods and optimizing the order of various treatment methods in the comprehensive treatment of each hepatocellular carcinoma patient, can we achieve the goal of improving the quality of life of hepatocellular carcinoma patients and prolonging the survival time of patients. Jin Yong's liver cancer died yesterday | Are you a high risk group for liver cancer?
